Trial NCT01636960

View at ClinicalTrials.gov 
Org. Study IDs: P08556
Secondary IDs: 132228 MK-4031-370

Last trial update was posted on 2018-08-08

MeSH Interventions

Peginterferon alfa-2b

MeSH Conditions

Melanoma

Other Conditions

Malignant Melanoma

Stopping Reasons

The study was terminated after 118 weeks from the study start, during the maintenance phase, due to regulatory approval in Japan.

Limitations And Caveats

The study was terminated after 118 weeks from the study start, during the maintenance phase, due to regulatory approval in Japan.

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID